LUXHT
Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
Full methodology- TickerLUXHT
- Inception Date04/27/2021
- WeightingCustom
- # of holdings56
What's inside?
Holdings
All holdings as of September 29, 2023
| Oscar Health, Inc. (OSCR) | 4.98% | $1.021B | 49.56% | N/A | 0.42x |
| Lifestance Health Group, Inc. (LFST) | 3.30% | $2.597B | 23.89% | 20.59% | 3.90x |
| Align Technology, Inc. (ALGN) | 3.18% | $23.367B | 3.36% | 71.69% | 7.02x |
| GoodRx Holdings, Inc. (GDRX) | 3.15% | $0.474B | -1.11% | 82.90% | 3.01x |
| NeoGenomics, Inc. (NEO) | 3.13% | $1.569B | 17.47% | 38.09% | 4.01x |
| EXACT Sciences Corp. (EXAS) | 3.01% | $12.325B | 19.26% | 71.08% | 8.14x |
| Schrödinger, Inc. (SDGR) | 2.87% | $1.773B | -8.53% | 39.25% | 17.10x |
| Accolade, Inc. (ACCD) | 2.84% | $0.800B | 9.00% | 30.05% | 2.41x |
| Natera, Inc. (NTRA) | 2.82% | $5.071B | 31.89% | 45.24% | 5.63x |
| Myriad Genetics, Inc. (MYGN) | 2.31% | $1.313B | 2.34% | 62.72% | 2.83x |
| Intuitive Surgical, Inc. (ISRG) | 2.26% | $102.697B | 15.36% | 66.66% | 17.47x |
| iRhythm Technologies, Inc. (IRTC) | 2.26% | $2.882B | 21.64% | 69.46% | 6.96x |
| Axonics, Inc. (AXNX) | 2.23% | $2.832B | 34.67% | 73.11% | 6.72x |
| Hims & Hers Health, Inc. (HIMS) | 2.22% | $1.275B | 83.08% | 80.70% | 2.49x |
| Hologic, Inc. (HOLX) | 2.21% | $16.999B | -1.83% | 54.85% | 4.97x |
| Progyny, Inc. (PGNY) | 2.16% | $3.246B | 43.27% | 21.71% | 3.86x |
| Veeva Systems, Inc. (VEEV) | 2.13% | $29.736B | 10.48% | 71.36% | 13.23x |
| IQVIA Holdings, Inc. (IQV) | 2.12% | $36.029B | 4.73% | 27.37% | 3.72x |
| Veracyte, Inc. (VCYT) | 2.09% | $1.625B | 23.96% | 60.08% | 5.08x |
| Definitive Healthcare Corp. (DH) | 2.06% | $0.905B | 11.75% | 65.79% | 6.71x |
| DexCom, Inc. (DXCM) | 2.06% | $36.188B | 25.15% | 62.52% | 17.26x |
| Inspire Medical Systems, Inc. (INSP) | 2.04% | $5.821B | 65.33% | 83.95% | 17.19x |
| Nano-X Imaging Ltd. (NNOX) | 2.03% | $0.376B | 17.36% | -69.25% | 82.09x |
| Guardant Health, Inc. (GH) | 2.03% | $3.488B | 25.66% | 60.74% | 7.90x |
| 10X Genomics, Inc. (TXG) | 2.01% | $4.264B | 28.10% | 61.08% | 10.95x |
| Fulgent Genetics, Inc. (FLGT) | 2.00% | $0.800B | -45.87% | 27.43% | 2.18x |
| Health Catalyst, Inc. (HCAT) | 2.00% | $0.576B | 3.65% | 31.70% | 2.13x |
| Clover Health Investments Corp. (CLOV) | 1.98% | $0.429B | -39.25% | N/A | 0.16x |
| Teladoc Health, Inc. (TDOC) | 1.92% | $3.066B | 10.13% | 59.23% | 1.89x |
| Pacific Biosciences of California, Inc. (PACB) | 1.85% | $2.092B | 34.13% | 32.58% | 23.49x |
| SomaLogic, Inc. (SLGC) | 1.27% | $0.449B | 44.71% | 45.40% | -0.40x |
| Sharecare, Inc. (SHCR) | 1.22% | $0.336B | 6.29% | 30.10% | 1.15x |
| NanoString Technologies, Inc. (NSTG) | 1.22% | $0.082B | 37.05% | 32.61% | 2.24x |
| ResMed, Inc. (RMD) | 1.16% | $21.747B | 22.66% | 53.92% | 7.95x |
| PROCEPT BioRobotics Corp. (PRCT) | 1.14% | $1.631B | 98.33% | 54.27% | 15.02x |
| Globus Medical, Inc. (GMED) | 1.13% | $5.826B | 10.61% | 72.22% | 4.97x |
| Olink Holding AB (OLK) | 1.12% | $1.819B | 6.93% | 58.74% | 14.97x |
| Nevro Corp. (NVRO) | 1.11% | $0.694B | 4.41% | 65.86% | 1.87x |
| Doximity, Inc. (DOCS) | 1.08% | $2.663B | 19.67% | 87.87% | 14.57x |
| 23andMe Holding Co. (ME) | 1.07% | $0.298B | -5.66% | 37.07% | 1.95x |
| Insulet Corp. (PODD) | 1.07% | $11.136B | 32.43% | 66.13% | 14.31x |
| Castle Biosciences, Inc. (CSTL) | 1.06% | $0.453B | 43.92% | 72.69% | 0.93x |
| Adaptive Biotechnologies Corp. (ADPT) | 1.05% | $0.788B | 12.06% | 51.84% | 4.13x |
| Twist Bioscience Corp. (TWST) | 1.04% | $1.163B | 13.59% | 34.35% | 3.83x |
| Tandem Diabetes Care, Inc. (TNDM) | 1.02% | $1.352B | -2.17% | 51.93% | 1.90x |
| Nautilus, Inc. (NLS) | 1.00% | $0.031B | -23.84% | 20.72% | 0.21x |
| Illumina, Inc. (ILMN) | 1.00% | $21.731B | 1.20% | 62.24% | 6.97x |
| CareDx, Inc. (CDNA) | 0.99% | $0.379B | -12.81% | 62.31% | 0.68x |
| Seer, Inc. (California) (SEER) | 0.99% | $0.132B | 10.69% | 23.03% | -1.17x |
| American Well Corp. (AMWL) | 0.97% | $0.295B | -3.21% | 26.40% | 0.61x |
| Outset Medical, Inc. (OM) | 0.96% | $0.542B | 43.83% | 21.37% | 7.36x |
| Masimo Corp. (MASI) | 0.96% | $4.631B | -19.46% | 48.58% | 4.47x |
| Cytek Biosciences, Inc. (CTKB) | 0.93% | $0.753B | 23.74% | 56.67% | 5.01x |
| Invitae Corp. (NVTA) | 0.85% | $0.162B | -11.78% | 27.43% | 3.15x |
| Butterfly Network, Inc. (BFLY) | 0.73% | $0.213B | -3.79% | 59.08% | 4.62x |
| Sight Sciences, Inc. (SGHT) | 0.63% | $0.164B | 36.23% | 85.59% | 3.46x |